CLASS EDITORI SPA (CLE.MI) Fundamental Analysis & Valuation

BIT:CLE • IT0005117848

Current stock price

0.1425 EUR
-0.01 (-5.63%)
Last:

This CLE.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. CLE.MI Profitability Analysis

1.1 Basic Checks

  • In the past year CLE has reported negative net income.
  • In the past year CLE had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CLE reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CLE reported negative operating cash flow in multiple years.
CLE.MI Yearly Net Income VS EBIT VS OCF VS FCFCLE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

1.2 Ratios

  • With a Return On Assets value of -1.81%, CLE is not doing good in the industry: 69.70% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -47.04%, CLE is doing worse than 75.76% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 2.24%, CLE is doing worse than 62.12% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for CLE is above the industry average of 7.69%.
  • The last Return On Invested Capital (2.24%) for CLE is well below the 3 year average (10.13%), which needs to be investigated, but indicates that CLE had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.81%
ROE -47.04%
ROIC 2.24%
ROA(3y)2.82%
ROA(5y)-1.7%
ROE(3y)44.72%
ROE(5y)N/A
ROIC(3y)10.13%
ROIC(5y)N/A
CLE.MI Yearly ROA, ROE, ROICCLE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

1.3 Margins

  • The Operating Margin of CLE (3.14%) is comparable to the rest of the industry.
  • CLE has a Gross Margin of 69.96%. This is in the better half of the industry: CLE outperforms 71.21% of its industry peers.
  • CLE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.14%
PM (TTM) N/A
GM 69.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y2.46%
CLE.MI Yearly Profit, Operating, Gross MarginsCLE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. CLE.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CLE is still creating some value.
  • Compared to 1 year ago, CLE has about the same amount of shares outstanding.
  • The number of shares outstanding for CLE has been increased compared to 5 years ago.
  • CLE has a worse debt/assets ratio than last year.
CLE.MI Yearly Shares OutstandingCLE.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLE.MI Yearly Total Debt VS Total AssetsCLE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • CLE has an Altman-Z score of -0.68. This is a bad value and indicates that CLE is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of CLE (-0.68) is worse than 81.82% of its industry peers.
  • The Debt to FCF ratio of CLE is 6.03, which is on the high side as it means it would take CLE, 6.03 years of fcf income to pay off all of its debts.
  • CLE has a Debt to FCF ratio (6.03) which is comparable to the rest of the industry.
  • A Debt/Equity ratio of 5.21 is on the high side and indicates that CLE has dependencies on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 5.21, CLE is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.21
Debt/FCF 6.03
Altman-Z -0.68
ROIC/WACC0.39
WACC5.77%
CLE.MI Yearly LT Debt VS Equity VS FCFCLE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 0.64 indicates that CLE may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.64, CLE is doing worse than 74.24% of the companies in the same industry.
  • A Quick Ratio of 0.63 indicates that CLE may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.63, CLE is doing worse than 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.63
CLE.MI Yearly Current Assets VS Current LiabilitesCLE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1

3. CLE.MI Growth Analysis

3.1 Past

  • CLE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -381.08%.
  • CLE shows a decrease in Revenue. In the last year, the revenue decreased by -0.71%.
  • CLE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.70% yearly.
EPS 1Y (TTM)-381.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.89%
Revenue 1Y (TTM)-0.71%
Revenue growth 3Y5.52%
Revenue growth 5Y0.7%
Sales Q2Q%3.71%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CLE.MI Yearly Revenue VS EstimatesCLE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1

4. CLE.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • CLE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CLE.MI Price Earnings VS Forward Price EarningsCLE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • CLE's Enterprise Value to EBITDA is on the same level as the industry average.
  • CLE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CLE is cheaper than 69.70% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.5
EV/EBITDA 7.35
CLE.MI Per share dataCLE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2 -0.2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CLE.MI Dividend Analysis

5.1 Amount

  • No dividends for CLE!.
Industry RankSector Rank
Dividend Yield 0%

CLE.MI Fundamentals: All Metrics, Ratios and Statistics

CLASS EDITORI SPA

BIT:CLE (3/20/2026, 7:00:00 PM)

0.1425

-0.01 (-5.63%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners76.14%
Ins Owner ChangeN/A
Market Cap45.99M
Revenue(TTM)75.85M
Net Income(TTM)-2.88M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.61
P/FCF 7.5
P/OCF 4.74
P/B 7.5
P/tB N/A
EV/EBITDA 7.35
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.02
FCFY13.33%
OCF(TTM)0.03
OCFY21.1%
SpS0.24
BVpS0.02
TBVpS-0.2
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.81%
ROE -47.04%
ROCE 3.78%
ROIC 2.24%
ROICexc 2.34%
ROICexgc N/A
OM 3.14%
PM (TTM) N/A
GM 69.96%
FCFM 8.08%
ROA(3y)2.82%
ROA(5y)-1.7%
ROE(3y)44.72%
ROE(5y)N/A
ROIC(3y)10.13%
ROIC(5y)N/A
ROICexc(3y)10.66%
ROICexc(5y)N/A
ROICexgc(3y)81.76%
ROICexgc(5y)N/A
ROCE(3y)15.71%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.44%
GM growth 5Y2.46%
F-Score5
Asset Turnover0.48
Health
Industry RankSector Rank
Debt/Equity 5.21
Debt/FCF 6.03
Debt/EBITDA 3.38
Cap/Depr 50.47%
Cap/Sales 4.71%
Interest Coverage 250
Cash Conversion 102.6%
Profit Quality N/A
Current Ratio 0.64
Quick Ratio 0.63
Altman-Z -0.68
F-Score5
WACC5.77%
ROIC/WACC0.39
Cap/Depr(3y)66.6%
Cap/Depr(5y)71.2%
Cap/Sales(3y)6.36%
Cap/Sales(5y)7.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-381.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%32.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.71%
Revenue growth 3Y5.52%
Revenue growth 5Y0.7%
Sales Q2Q%3.71%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-75.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.3%
OCF growth 3YN/A
OCF growth 5YN/A

CLASS EDITORI SPA / CLE.MI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CLASS EDITORI SPA (CLE.MI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CLE.MI.


Can you provide the valuation status for CLASS EDITORI SPA?

ChartMill assigns a valuation rating of 1 / 10 to CLASS EDITORI SPA (CLE.MI). This can be considered as Overvalued.


Can you provide the profitability details for CLASS EDITORI SPA?

CLASS EDITORI SPA (CLE.MI) has a profitability rating of 3 / 10.


What is the financial health of CLASS EDITORI SPA (CLE.MI) stock?

The financial health rating of CLASS EDITORI SPA (CLE.MI) is 1 / 10.